共 50 条
- [1] Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (15):
- [6] Treatment of HBV infection reduces the risk of hepatocellular carcinoma [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2009, 6 (1): : 2 - 2
- [7] Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (10):
- [9] Revisiting the relationship between baseline risk and risk under treatment [J]. Emerging Themes in Epidemiology, 6 (1):
- [10] Association of dynamic changes in serum levels of HBV DNA and risk of hepatocellular carcinoma [J]. Current Medicine, 1 (1):